Osaic Holdings
MDGL icon

Osaic Holdings’s Madrigal Pharmaceuticals MDGL Stock Holding History

Osaic Holdings’s Portfolio MDGL Stock Details MDGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-1
Closed -$10.4K – 7611
2024
Q4 		$10.4K Hold
1
– – ﹤0.01% 5785
2024
Q3 		$3.65K Hold
1
– – ﹤0.01% 6354
2024
Q2 		$9.5K Hold
1
– – ﹤0.01% 5827
2024
Q1 		$9.36K Hold
1
– – ﹤0.01% 5778
2023
Q4 		$7.76K Buy
+1
New +$175 ﹤0.01% 5959

Other funds holding MDGL

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
PC
Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Osaic Holdings's MDGL Position: Q2 2026 in Review

Osaic Holdings reduced its Madrigal Pharmaceuticals (MDGL) stake by 78% in Q2 2026, selling an estimated $1.61M and leaving 890 shares worth $478K. The position accounts for ﹤0.01% of the portfolio, ranked #3711.

Osaic Holdings first reported a position in MDGL in Q1 2020 and has held it in 26 quarters since. The position peaked at $2.63M in Q2 2025. 414 funds tracked by Wall St. Rank hold MDGL as of Q2 2026.

  • Osaic Holdings held 890 shares of Madrigal Pharmaceuticals worth $478K as of Q2 2026.
  • Osaic Holdings sold 3,150 Madrigal Pharmaceuticals shares in Q2 2026, an estimated $1.61M.
  • Madrigal Pharmaceuticals made up ﹤0.01% of Osaic Holdings's portfolio in Q2 2026, its #3711 holding.
  • Osaic Holdings first reported a position in Madrigal Pharmaceuticals in Q1 2020 and has held it in 26 quarters since.
  • Osaic Holdings's Madrigal Pharmaceuticals position peaked at $2.63M in Q2 2025.
  • 414 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.